Description

Tomohexol (iohexol) 300 mg/ml. 20 ml. #1 vial

Tomohexol is a contrast agent used in medical imaging procedures to enhance the visibility of blood vessels, organs, and tissues during diagnostic tests such as CT scans and angiograms. It contains iohexol as the active ingredient, with a concentration of 300 mg/ml. in a 20 ml. vial.

Uses

Tomohexol is primarily used to improve the quality of images obtained during radiographic procedures. It is commonly employed in the following diagnostic tests:

• Computed Tomography (CT) scans
• Angiography
• Myelography
• Cystography

Mechanism of Action

Iohexol, the active ingredient in Tomohexol, is an iodinated contrast medium. It works by altering the density of the body tissues it comes in contact with, thereby enhancing the visibility of blood vessels, organs, or other structures being examined. This improved contrast allows healthcare providers to obtain clearer images for accurate diagnosis and treatment planning.

Administration

Tomohexol is typically administered intravenously before the imaging procedure. The dosage and administration technique may vary depending on the specific medical indication and the patient’s individual characteristics. Healthcare providers should follow the recommended guidelines and protocols for the safe and effective use of Tomohexol.

Precautions

Before administering Tomohexol, healthcare providers should consider the following precautions:

• Assess the patient’s medical history, including any allergies, previous reactions to contrast agents, and renal function.
• Ensure adequate hydration before and after the procedure to reduce the risk of contrast-induced nephropathy.
• Monitor the patient for any signs of adverse reactions, such as allergic responses or contrast-induced nephropathy.

Side Effects

Common side effects associated with the use of Tomohexol may include:

• Nausea
• Headache
• Flushing
• Dizziness
• Injection site reactions

Serious side effects, although rare, may include anaphylaxis (severe allergic reaction) and contrast-induced nephropathy (kidney damage). Healthcare providers should be prepared to manage these complications promptly if they occur.

Interactions

Tomohexol may interact with certain medications or conditions, potentially affecting its safety and efficacy. Healthcare providers should be aware of the following interactions:

• Drugs that affect renal function, such as NSAIDs or diuretics, may increase the risk of contrast-induced nephropathy.
• Prior exposure to iodinated contrast agents may increase the risk of hypersensitivity reactions with subsequent administrations.

Storage

Tomohexol should be stored in a cool, dry place away from direct sunlight and heat. The vial should be checked for any signs of damage or contamination before use. Once opened, any unused portion of the product should be discarded according to local regulations and guidelines.

Conclusion

Tomohexol is a valuable contrast agent used in diagnostic imaging procedures to improve the visualization of internal structures and facilitate accurate diagnosis. Healthcare providers should be knowledgeable about its indications, administration, precautions, and potential side effects to ensure safe and effective use in clinical practice.